Year All202320222021202020192018 July 26, 2023 Oculis Announces to Present at Upcoming August Investor Conferences July 19, 2023 Oculis to Present at OIS Retina Innovation Summit June 26, 2023 Oculis to Host an R&D Retina Day to Showcase Clinical Programs Targeting Diabetic Macular Edema and Other Retina Diseases on Tuesday, July 11, 2023 June 13, 2023 Oculis Announces Partial Exercise of Underwriters’ Option to Purchase Additional Ordinary Shares June 12, 2023 Oculis Wins the 2023 Icelandic Knowledge Award from the Icelandic Association of Business and Economics June 1, 2023 Oculis to Participate in Jefferies Healthcare Conference May 31, 2023 Oculis Announces Pricing of $40.25 Million Public Offering of Ordinary Shares May 31, 2023 Oculis Announces Upcoming Presentation of Positive Stage 1 Top Line Results from Phase 3 DIAMOND Trial at Clinical Trials at the Summit (CTS) May 30, 2023 Oculis Announces Launch of Proposed Public Offering of Ordinary Shares May 24, 2023 Oculis to Participate and Present at Upcoming EuDES Meeting
June 26, 2023 Oculis to Host an R&D Retina Day to Showcase Clinical Programs Targeting Diabetic Macular Edema and Other Retina Diseases on Tuesday, July 11, 2023
June 13, 2023 Oculis Announces Partial Exercise of Underwriters’ Option to Purchase Additional Ordinary Shares
June 12, 2023 Oculis Wins the 2023 Icelandic Knowledge Award from the Icelandic Association of Business and Economics
May 31, 2023 Oculis Announces Upcoming Presentation of Positive Stage 1 Top Line Results from Phase 3 DIAMOND Trial at Clinical Trials at the Summit (CTS)
